| Predicate |
Object |
| contentType |
Comment|Journal Article |
| endingPage |
359 |
| issn |
1743-4297
1743-4300 |
| issueIdentifier |
7 |
| pageRange |
358-359 |
| publicationName |
Nature clinical practice. Cardiovascular medicine |
| startingPage |
358 |
| bibliographicCitation |
Schulman S. Can fondaparinux safely prevent the occurrence of venous thromboembolism in acutely ill medical patients? Nature Clinical Practice Cardiovascular Medicine. 2006 Jul;3(7):358–9. doi: 10.1038/ncpcardio0582. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_776adf9c8af86bf14ac891335e838981
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8512-9043 |
| date |
200607 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/16810167
https://doi.org/10.1038/ncpcardio0582 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1743-4300
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32523
https://portal.issn.org/resource/ISSN/1743-4297 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Can fondaparinux safely prevent the occurrence of venous thromboembolism in acutely ill medical patients? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448 |